Susquehanna Fundamental Investments’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,413
Closed -$468K 714
2025
Q1
$468K Sell
9,413
-10,934
-54% -$691K 0.01% 864
2024
Q4
$1.42M Buy
+20,347
New +$1.69M 0.02% 621
2024
Q2
$3.94M Buy
27,735
+8,575
+45% +$989K 0.09% 269
2024
Q1
$2.14M Buy
+19,160
New +$2.28M 0.1% 222
2023
Q4
Sell
-5,300
Closed -$864K 72
2023
Q3
$864K Sell
5,300
-28,292
-84% -$4.98M 0.06% 212
2023
Q2
$6.16M Hold
33,592
0.23% 125
2023
Q1
$4.48M Hold
33,592
0.1% 241
2022
Q4
$2.67M Sell
33,592
-3,508
-9% -$247K 0.05% 415
2022
Q3
$2.25M Buy
+37,100
New +$2.4M 0.04% 544
2022
Q1
$1.95M Buy
25,838
+19,438
+304% +$1.33M 0.04% 592
2021
Q4
$477K Sell
6,400
-6,586
-51% -$390K 0.01% 935
2021
Q3
$611K Buy
12,986
+4,600
+55% +$200K 0.01% 1104
2021
Q2
$339K Sell
8,386
-2,900
-26% -$120K 0.01% 1322
2021
Q1
$464K Hold
11,286
0.01% 1164
2020
Q4
$329K Buy
+11,286
New +$292K 0.01% 1246

Other funds holding ACLS

Susquehanna Fundamental Investments's ACLS Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Axcelis (ACLS) in Q2 2025, closing a stake of 9,413 shares — an estimated $468K sold.

Susquehanna Fundamental Investments first reported a position in ACLS in Q4 2020 and held it in 15 quarters. The position peaked at $6.16M in Q2 2023. 328 funds tracked by Wall St. Rank hold ACLS as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining Axcelis position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 9,413 Axcelis shares in Q2 2025, an estimated $468K.
  • Susquehanna Fundamental Investments first reported a position in Axcelis in Q4 2020 and held it in 15 quarters.
  • Susquehanna Fundamental Investments's Axcelis position peaked at $6.16M in Q2 2023.
  • 328 funds tracked by Wall St. Rank held Axcelis as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.